New prototype based on EPGL contact lens technology to undergo FDA testing next year

Without disclosing the name, EPGL said it has partnered with a public company to create a new contact lens prototype that will undergo FDA testing as early as next year

Must Read

How AI monitoring can make your business smarter and better

Artificial Intelligence (AI) makes it feasible for machines to learn from experience, adapt to new inputs, and perform human-like tasks.

Why cybersecurity threats have increased during Covid-19 pandemic

Cybersecurity industry has never had more significant task to carry out than guarding strategic associations and businesses from digital assaults during the coronavirus pandemic

How to choose an effective DDoS mitigation plan

There are several flavours from which to choose when selecting an effective DDoS mitigation strategy. Most enterprises opt for one of the cloud protection flavours (always-on or on-demand)

Without disclosing the name of the public company, the EP Global Communications (EPGL) which last year acquired 100% stake of ophthalmic IP portfolio said that “one of the world’s leading multi-billion-dollar public companies has made EPGL technology and its patented Elastic Circuit technology as the choice for a proprietary development of a new contact lens prototype to undergo FDA testing as early as next year.” Company said that “this goes beyond a right of first negotiation to now having EPGL technology at the center of a commercial project that addresses a multi-billion-dollar market in the field.”

“We are on target with our strategy and the proof is that major companies are now choosing EPGL tech for actual market commercialisation, not just first rights. Just as the number of our patents has grown, the number of corporate suitors for our technology will grow exponentially,” stated Michael Hayes, President, .

EPGL is a US-based advanced technology research and development company for both medical devices and consumer electronics devices specialising in microelectronic mechanical systems (MEMS). Last year, it had announced settlement with CooperVision in which it gained full ownership of its pending patents. After getting approval for some of its patent, the company has now announced its first partnership.

In the past, EPGL’s smart contact lens technology has drawn interest from industry heavyweights like Johnson & Johnson and Vision Care among others. In fact, in September 2016, it had an introductory conversation with Apple about the iOS platform for augmented lens development program.

EPGL claimed that it is the only company to publicly show electronic circuitry material in a photo; which has been proven to integrate distortion free into real silicone hydrogel contact lenses and can enhance the experience for AR and devices.

Subscribe to receive the day's headlines from Tech Observer straight in your inbox

Share your views

*The moderation of comments is automated and not cleared manually by Embedding of any link and use of abusive or unparliamentary language are prohibited.
- Advertisement -

Latest in TECH

Related Articles